Kotler Kevin
In its 13F for Q4 2025 (holdings as of December 31, 2025, filed February 17, 2026), Kotler Kevin reported 34 stock positions worth $135.4 million. Its top holding was Angiodynamics (ANGO) at 16.3% of the portfolio, followed by Aurinia Pharmaceuticals (AUPH, 14.4%) and Avadel Pharmaceuticals (AVDL, 11.8%).
- Most Recent 13F
- Q4 2025
- Location
- MELVILLE, NY
- CIK
- 0001601692
- Portfolio Value
- $135.4M (Q4 2025)
- SEC Filing
- 0000919574-26-001069 ↗ filed Feb 17, 2026
Holdings 34 stocks · $135.4M
| ANGO Angiodynamics Inc. | 16.25% | 1,713,789 | $22.0M | — |
| AUPH Aurinia Pharmaceuticals Inc. | 14.43% | 1,224,846 | $19.5M | — |
| AVDL Avadel Pharmaceuticals Ltd. | 11.80% | 741,343 | $16.0M | — |
| OMER Omeros Corp. | 11.49% | 905,635 | $15.6M | — |
| NPCE Neuropace Inc. | 7.20% | 631,468 | $9.7M | — |
| MDWD Mediwound Ltd. | 4.60% | 337,236 | $6.2M | — |
| AXGN Axogen Inc. | 4.06% | 168,000 | $5.5M | — |
| IART Integra Lifesciences Holding | 3.92% | 427,445 | $5.3M | — |
| ACRS Aclaris Therapeutics Inc. | 3.79% | 1,705,929 | $5.1M | — |
| EVTL Vertical Aerospace Ltd. | 3.70% | 939,705 | $5.0M | — |
| OSUR Orasure Technologies Inc. | 3.22% | 1,801,446 | $4.4M | — |
| LKFT Lakefront Biotherapeutic-ADR filed as GALAPAGOS NV | 2.17% | 90,000 | $2.9M | — |
| LLY Eli Lilly & Co. | 1.59% | 2,000 | $2.1M | — |
| CERS Cerus Corp. | 1.54% | 1,011,614 | $2.1M | — |
| NKE Nike Inc. Class B | 1.51% | 32,000 | $2.0M | — |
| TECX Tectonic Therapeutic Inc. | 1.23% | 80,000 | $1.7M | — |
| CLYM Climb Bio Inc. | 1.18% | 400,000 | $1.6M | — |
| TMCI Treace Medical Concepts Inc. | 0.86% | 474,365 | $1.2M | — |
| TLSI Trisalus Life Sciences Inc. | 0.75% | 145,200 | $1.0M | — |
| DXCM Dexcom Inc. | 0.74% | 15,000 | $996K | — |
| VNDA Vanda Pharmaceuticals Inc. | 0.65% | 100,000 | $882K | — |
| ALGN Align Technology Inc. | 0.50% | 4,359 | $681K | — |
| OKUR Onkure Therapeutics Inc. Class A | 0.42% | 197,691 | $573K | — |
| GE General Electric filed as GE AEROSPACE | 0.33% | 1,468 | $452K | — |
| LUNG Pulmonx Corp. | 0.33% | 200,000 | $442K | — |
| PTCT PTC Therapeutics Inc. | 0.28% | 5,000 | $380K | — |
| DY Dycom Industries Inc. | 0.26% | 1,051 | $355K | — |
| TAK Takeda Pharmaceutic-SP ADR | 0.23% | 20,000 | $312K | — |
| BBNX Beta Bionics Inc. | 0.18% | 8,216 | $250K | — |
| IHI iShares U.S. Medical Devices | 0.18% | 3,902 | $243K | — |
| BAC Bank of America Corp. filed as BANK AMERICA CORP | 0.18% | 4,392 | $242K | — |
| AMZN Amazon.com Inc. | 0.17% | 1,000 | $231K | — |
| ELAN Elanco Animal Health Inc. | 0.15% | 9,072 | $205K | — |
| PLRX Pliant Therapeutics Inc. | 0.08% | 93,000 | $113K | — |
Options reported separately and not counted above: SPY puts ($238.7M), QQQ puts ($30.7M), AVDL calls ($19.0M), OMER calls ($3.8M).
Portfolio Sells Q4 2025
No earlier filing to compare with.
Portfolio Buys Q4 2025
No earlier filing to compare with.
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q4 2025 | 34 | $135.4M | ANGO, AUPH, AVDL, OMER, NPCE |